APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antiepileptic Drugs，AEDs

Epilepsy is a chronic brain disease caused by multiple causes and characterized by recurrent, unprovoked seizures. At present, it is mainly believed that epilepsy is characterized by repeated, episodic and transient central nervous system dysfunction caused by excessive discharge of brain neurons. Epilepsy is usually diagnosed when two or more unprovoked epileptic seizures occur. Partial seizures are the most common. Uncontrolled seizures are associated with lifestyle restrictions and social impairment and can lead to serious adverse outcomes, including severe trauma, depression, anxiety, and sudden death. Antiepileptic drugs (AEDs), also known as anticonvulsants, are drugs used to prevent epilepsy (epilepsy) attacks. People with epilepsy need to take one or more AEDs regularly. AEDs interact with nerve cells in the brain, often reducing their activity. Different AEDs work through a variety of mechanisms, so each type of epilepsy responds to some AEDs and not others

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Epilepsy is a chronic brain disease caused by multiple causes and characterized by recurrent, unprovoked seizures. At present, it is mainly believed that epilepsy is characterized by repeated, episodic and transient central nervous system dysfunction caused by excessive discharge of brain neurons. Epilepsy is usually diagnosed when two or more unprovoked epileptic seizures occur. Partial seizures are the most common. Uncontrolled seizures are associated with lifestyle restrictions and social impairment and can lead to serious adverse outcomes, including severe trauma, depression, anxiety, and sudden death. Antiepileptic drugs (AEDs), also known as anticonvulsants, are drugs used to prevent epilepsy (epilepsy) attacks. People with epilepsy need to take one or more AEDs regularly. AEDs interact with nerve cells in the brain, often reducing their activity. Different AEDs work through a variety of mechanisms, so each type of epilepsy responds to some AEDs and not others

Selected research

Industry Growth & Trends

Global Antiepileptic Drugs，AEDs Industry Growth and Trends Forecast to 2032

21 December 2025126 pages

Choose your research edition.

Industry ResearchAntiepileptic Drugs，AEDs Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Antiepileptic Drugs，AEDs Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Antiepileptic Drugs，AEDs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antiepileptic Drugs，AEDs Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Antiepileptic Drugs，AEDs Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

Epilepsy is a chronic brain disease caused by multiple causes and characterized by recurrent, unprovoked seizures. At present, it is mainly believed that epilepsy is characterized by repeated, episodic and transient central nervous system dysfunction caused by excessive discharge of brain neurons. Epilepsy is usually diagnosed when two or more unprovoked epileptic seizures occur. Partial seizures are the most common. Uncontrolled seizures are associated with lifestyle restrictions and social impairment and can lead to serious adverse outcomes, including severe trauma, depression, anxiety, and sudden death. Antiepileptic drugs (AEDs), also known as anticonvulsants, are drugs used to prevent epilepsy (epilepsy) attacks. People with epilepsy need to take one or more AEDs regularly. AEDs interact with nerve cells in the brain, often reducing their activity. Different AEDs work through a variety of mechanisms, so each type of epilepsy responds to some AEDs and not others

The global Antiepileptic Drugs，AEDs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antiepileptic Drugs，AEDs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

Read the full market overview

The Europe market for Antiepileptic Drugs，AEDs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

The Asia Pacific market for Antiepileptic Drugs，AEDs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antiepileptic Drugs，AEDs include Novartis, Pfizer, GlaxoSmithKline, Eisai, Roche, Shanghai Pharmaceuticals Holding, Gilead Sciences, UCB and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antiepileptic Drugs，AEDs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antiepileptic Drugs，AEDs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antiepileptic Drugs，AEDs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antiepileptic Drugs，AEDs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antiepileptic Drugs，AEDs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antiepileptic Drugs，AEDs Market by Company

Novartis

Pfizer

GlaxoSmithKline

Eisai

Roche

Shanghai Pharmaceuticals Holding

Gilead Sciences

UCB

Johnson & Johnson

Lupin Pharmaceuticals

Mylan N.V.

Sanofi

Teva Pharmaceutical Industries

Abbott

Sunovion

Shenzhen Salubris Pharmaceuticals

Chongqing Shenghuaxi Pharm

Zhejiang Jingxin Pharmaceutical

Zhuhai United Laboratories

Hubei Jumpcan Pharmaceutical

Zhejiang Huahai Pharmaceutical

China Resources SAIKE Pharmaceutical

Sihuan Pharmaceutical Holdings

Apeloa Pharmaceutical

Sandoz

Aurobindo Pharma

Yangtze River Pharmaceutical

Antiepileptic Drugs，AEDs Segment by Type

First Generation AEDs

Second Generation AEDs

Third Generation AEDs

Antiepileptic Drugs，AEDs Segment by Application

≤15 Years Old

15～40 Years Old

>40～65 Years Old

>65 Years Old

Antiepileptic Drugs，AEDs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antiepileptic Drugs，AEDs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antiepileptic Drugs，AEDs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antiepileptic Drugs，AEDs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antiepileptic Drugs，AEDs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antiepileptic Drugs，AEDs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of First Generation AEDs Table 2. Major Company of Second Generation AEDs Table 3. Major Company of Third Generation AEDs Table 4. Global Antiepileptic Drugs，AEDs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Antiepileptic Drugs，AEDs Sales by Type (2021-2026) & (K Units) Table 6. Global Antiepileptic Drugs，AEDs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Antiepileptic Drugs，AEDs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Antiepileptic Drugs，AEDs Sales Market Share in Value by Type (2021-2026) Table 9. Global Antiepileptic Drugs，AEDs Price by Type (2021-2026) & (US$/Unit) Table 10. Global Antiepileptic Drugs，AEDs Sales by Type (2027-2032) & (K Units) Table 11. Global Antiepileptic Drugs，AEDs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Antiepileptic Drugs，AEDs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Antiepileptic Drugs，AEDs Sales Market Share in Value by Type (2027-2032) Table 14. Global Antiepileptic Drugs，AEDs Price by Type (2027-2032) & (US$/Unit) Table 15. North America Antiepileptic Drugs，AEDs Sales by Type (2021-2026) & (K Units) Table 16. North America Antiepileptic Drugs，AEDs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Antiepileptic Drugs，AEDs Sales by Type (2021-2026) & (K Units) Table 18. Europe Antiepileptic Drugs，AEDs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Antiepileptic Drugs，AEDs Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Antiepileptic Drugs，AEDs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Antiepileptic Drugs，AEDs Sales by Type (2021-2026) & (K Units) Table 22. Latin America Antiepileptic Drugs，AEDs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Antiepileptic Drugs，AEDs Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Antiepileptic Drugs，AEDs Sales by Type (2021-2026) & (US$ Million) Table 25. Antiepileptic Drugs，AEDs Industry Trends Table 26. Antiepileptic Drugs，AEDs Industry Drivers Table 27. Antiepileptic Drugs，AEDs Industry Opportunities and Challenges Table 28. Antiepileptic Drugs，AEDs Industry Restraints Table 29. Global Antiepileptic Drugs，AEDs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Antiepileptic Drugs，AEDs Revenue Market Share by Company (2021-2026) Table 31. Global Antiepileptic Drugs，AEDs Sales by Company (2021-2026) & (K Units) Table 32. Global Antiepileptic Drugs，AEDs Sales Share by Company (2021-2026) Table 33. Global Antiepileptic Drugs，AEDs Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Antiepileptic Drugs，AEDs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Antiepileptic Drugs，AEDs Major Company Production Sites and Headquarters Table 36. Global Antiepileptic Drugs，AEDs Company, Product Type & Application Table 37. Global Antiepileptic Drugs，AEDs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Antiepileptic Drugs，AEDs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Antiepileptic Drugs，AEDs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Antiepileptic Drugs，AEDs Sales by Region (2021-2026) & (K Units) Table 42. Global Antiepileptic Drugs，AEDs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Antiepileptic Drugs，AEDs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Antiepileptic Drugs，AEDs Sales Market Share in Value by Region (2021-2026) Table 45. Global Antiepileptic Drugs，AEDs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Antiepileptic Drugs，AEDs Sales by Region (2027-2032) & (K Units) Table 47. Global Antiepileptic Drugs，AEDs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Antiepileptic Drugs，AEDs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Antiepileptic Drugs，AEDs Sales Market Share in Value by Region (2027-2032) Table 50. Global Antiepileptic Drugs，AEDs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Antiepileptic Drugs，AEDs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Antiepileptic Drugs，AEDs Sales by Application (2021-2026) & (K Units) Table 53. Global Antiepileptic Drugs，AEDs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Antiepileptic Drugs，AEDs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Antiepileptic Drugs，AEDs Sales Market Share in Value by Application (2021-2026) Table 56. Global Antiepileptic Drugs，AEDs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Antiepileptic Drugs，AEDs Sales by Application (2027-2032) & (K Units) Table 58. Global Antiepileptic Drugs，AEDs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Antiepileptic Drugs，AEDs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Antiepileptic Drugs，AEDs Sales Market Share in Value by Application (2027-2032) Table 61. Global Antiepileptic Drugs，AEDs Price by Application (2027-2032) & (US$/Unit) Table 62. North America Antiepileptic Drugs，AEDs Sales by Application (2021-2026) & (K Units) Table 63. North America Antiepileptic Drugs，AEDs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Antiepileptic Drugs，AEDs Sales by Application (2021-2026) & (K Units) Table 65. Europe Antiepileptic Drugs，AEDs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Antiepileptic Drugs，AEDs Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Antiepileptic Drugs，AEDs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Antiepileptic Drugs，AEDs Sales by Application (2021-2026) & (K Units) Table 69. Latin America Antiepileptic Drugs，AEDs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Antiepileptic Drugs，AEDs Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Antiepileptic Drugs，AEDs Sales by Application (2021-2026) & (US$ Million) Table 72. Novartis Company Information Table 73. Novartis Business Overview Table 74. Novartis Antiepileptic Drugs，AEDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Novartis Antiepileptic Drugs，AEDs Product Portfolio Table 76. Novartis Recent Development Table 77. Pfizer Company Information Table 78. Pfizer Business Overview Table 79. Pfizer Antiepileptic Drugs，AEDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Pfizer Antiepileptic Drugs，AEDs Product Portfolio Table 81. Pfizer Recent Development Table 82. GlaxoSmithKline Company Information Table 83. GlaxoSmithKline Business Overview Table 84. GlaxoSmithKline Antiepileptic Drugs，AEDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. GlaxoSmithKline Antiepileptic Drugs，AEDs Product Portfolio Table 86. GlaxoSmithKline Recent Development Table 87. Eisai Company Information Table 88. Eisai Business Overview Table 89. Eisai Antiepileptic Drugs，AEDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Eisai Antiepileptic Drugs，AEDs Product Portfolio Table 91. Eisai Recent Development Table 92. Roche Company Information Table 93. Roche Business Overview Table 94. Roche Antiepileptic Drugs，AEDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Roche Antiepileptic Drugs，AEDs Product Portfolio Table 96. Roche Recent Development Table 97. Shanghai Pharmaceuticals Holding Company Information Table 98. Shanghai Pharmaceuticals Holding Business Overview Table 99. Shanghai Pharmaceuticals Holding Antiepileptic Drugs，AEDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Shanghai Pharmaceuticals Holding Antiepileptic Drugs，AEDs Product Portfolio Table 101. Shanghai Pharmaceuticals Holding Recent Development Table 102. Gilead Sciences Company Information Table 103. Gilead Sciences Business Overview Table 104. Gilead Sciences Antiepileptic Drugs，AEDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Gilead Sciences Antiepileptic Drugs，AEDs Product Portfolio Table 106. Gilead Sciences Recent Development Table 107. UCB Company Information Table 108. UCB Business Overview Table 109. UCB Antiepileptic Drugs，AEDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. UCB Antiepileptic Drugs，AEDs Product Portfolio Table 111. UCB Recent Development Table 112. Johnson & Johnson Company Information Table 113. Johnson & Johnson Business Overview Table 114. Johnson & Johnson Antiepileptic Drugs，AEDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Johnson & Johnson Antiepileptic Drugs，AEDs Product Portfolio Table 116. Johnson & Johnson Recent Development Table 117. Lupin Pharmaceuticals Company Information Table 118. Lupin Pharmaceuticals Business Overview Table 119. Lupin Pharmaceuticals Antiepileptic Drugs，AEDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Lupin Pharmaceuticals Antiepileptic Drugs，AEDs Product Portfolio Table 121. Lupin Pharmaceuticals Recent Development Table 122. Mylan N.V. Company Information Table 123. Mylan N.V. Business Overview Table 124. Mylan N.V. Antiepileptic Drugs，AEDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Mylan N.V. Antiepileptic Drugs，AEDs Product Portfolio Table 126. Mylan N.V. Recent Development Table 127. Sanofi Company Information Table 128. Sanofi Business Overview Table 129. Sanofi Antiepileptic Drugs，AEDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Sanofi Antiepileptic Drugs，AEDs Product Portfolio Table 131. Sanofi Recent Development Table 132. Teva Pharmaceutical Industries Company Information Table 133. Teva Pharmaceutical Industries Business Overview Table 134. Teva Pharmaceutical Industries Antiepileptic Drugs，AEDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Teva Pharmaceutical Industries Antiepileptic Drugs，AEDs Product Portfolio Table 136. Teva Pharmaceutical Industries Recent Development Table 137. Abbott Company Information Table 138. Abbott Business Overview Table 139. Abbott Antiepileptic Drugs，AEDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Abbott Antiepileptic Drugs，AEDs Product Portfolio Table 141. Abbott Recent Development Table 142. Sunovion Company Information Table 143. Sunovion Business Overview Table 144. Sunovion Antiepileptic Drugs，AEDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Sunovion Antiepileptic Drugs，AEDs Product Portfolio Table 146. Sunovion Recent Development Table 147. Shenzhen Salubris Pharmaceuticals Company Information Table 148. Shenzhen Salubris Pharmaceuticals Business Overview Table 149. Shenzhen Salubris Pharmaceuticals Antiepileptic Drugs，AEDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Shenzhen Salubris Pharmaceuticals Antiepileptic Drugs，AEDs Product Portfolio Table 151. Shenzhen Salubris Pharmaceuticals Recent Development Table 152. Chongqing Shenghuaxi Pharm Company Information Table 153. Chongqing Shenghuaxi Pharm Business Overview Table 154. Chongqing Shenghuaxi Pharm Antiepileptic Drugs，AEDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Chongqing Shenghuaxi Pharm Antiepileptic Drugs，AEDs Product Portfolio Table 156. Chongqing Shenghuaxi Pharm Recent Development Table 157. Zhejiang Jingxin Pharmaceutical Company Information Table 158. Zhejiang Jingxin Pharmaceutical Business Overview Table 159. Zhejiang Jingxin Pharmaceutical Antiepileptic Drugs，AEDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Zhejiang Jingxin Pharmaceutical Antiepileptic Drugs，AEDs Product Portfolio Table 161. Zhejiang Jingxin Pharmaceutical Recent Development Table 162. Zhuhai United Laboratories Company Information Table 163. Zhuhai United Laboratories Business Overview Table 164. Zhuhai United Laboratories Antiepileptic Drugs，AEDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. Zhuhai United Laboratories Antiepileptic Drugs，AEDs Product Portfolio Table 166. Zhuhai United Laboratories Recent Development Table 167. Hubei Jumpcan Pharmaceutical Company Information Table 168. Hubei Jumpcan Pharmaceutical Business Overview Table 169. Hubei Jumpcan Pharmaceutical Antiepileptic Drugs，AEDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 170. Hubei Jumpcan Pharmaceutical Antiepileptic Drugs，AEDs Product Portfolio Table 171. Hubei Jumpcan Pharmaceutical Recent Development Table 172. Zhejiang Huahai Pharmaceutical Company Information Table 173. Zhejiang Huahai Pharmaceutical Business Overview Table 174. Zhejiang Huahai Pharmaceutical Antiepileptic Drugs，AEDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 175. Zhejiang Huahai Pharmaceutical Antiepileptic Drugs，AEDs Product Portfolio Table 176. Zhejiang Huahai Pharmaceutical Recent Development Table 177. China Resources SAIKE Pharmaceutical Company Information Table 178. China Resources SAIKE Pharmaceutical Business Overview Table 179. China Resources SAIKE Pharmaceutical Antiepileptic Drugs，AEDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 180. China Resources SAIKE Pharmaceutical Antiepileptic Drugs，AEDs Product Portfolio Table 181. China Resources SAIKE Pharmaceutical Recent Development Table 182. Sihuan Pharmaceutical Holdings Company Information Table 183. Sihuan Pharmaceutical Holdings Business Overview Table 184. Sihuan Pharmaceutical Holdings Antiepileptic Drugs，AEDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 185. Sihuan Pharmaceutical Holdings Antiepileptic Drugs，AEDs Product Portfolio Table 186. Sihuan Pharmaceutical Holdings Recent Development Table 187. Apeloa Pharmaceutical Company Information Table 188. Apeloa Pharmaceutical Business Overview Table 189. Apeloa Pharmaceutical Antiepileptic Drugs，AEDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 190. Apeloa Pharmaceutical Antiepileptic Drugs，AEDs Product Portfolio Table 191. Apeloa Pharmaceutical Recent Development Table 192. Sandoz Company Information Table 193. Sandoz Business Overview Table 194. Sandoz Antiepileptic Drugs，AEDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 195. Sandoz Antiepileptic Drugs，AEDs Product Portfolio Table 196. Sandoz Recent Development Table 197. Aurobindo Pharma Company Information Table 198. Aurobindo Pharma Business Overview Table 199. Aurobindo Pharma Antiepileptic Drugs，AEDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 200. Aurobindo Pharma Antiepileptic Drugs，AEDs Product Portfolio Table 201. Aurobindo Pharma Recent Development Table 202. Yangtze River Pharmaceutical Company Information Table 203. Yangtze River Pharmaceutical Business Overview Table 204. Yangtze River Pharmaceutical Antiepileptic Drugs，AEDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 205. Yangtze River Pharmaceutical Antiepileptic Drugs，AEDs Product Portfolio Table 206. Yangtze River Pharmaceutical Recent Development Table 207. North America Antiepileptic Drugs，AEDs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 208. North America Antiepileptic Drugs，AEDs Sales by Country (2021-2026) & (K Units) Table 209. North America Antiepileptic Drugs，AEDs Sales Market Share by Country (2021-2026) Table 210. North America Antiepileptic Drugs，AEDs Sales Forecast by Country (2027-2032) & (K Units) Table 211. North America Antiepileptic Drugs，AEDs Sales Market Share Forecast by Country (2027-2032) Table 212. North America Antiepileptic Drugs，AEDs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 213. North America Antiepileptic Drugs，AEDs Market Size by Country (2021-2026) & (US$ Million) Table 214. North America Antiepileptic Drugs，AEDs Market Share by Country (2021-2026) Table 215. North America Antiepileptic Drugs，AEDs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 216. North America Antiepileptic Drugs，AEDs Market Share Forecast by Country (2027-2032) Table 217. Europe Antiepileptic Drugs，AEDs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 218. Europe Antiepileptic Drugs，AEDs Sales by Country (2021-2026) & (K Units) Table 219. Europe Antiepileptic Drugs，AEDs Sales Market Share by Country (2021-2026) Table 220. Europe Antiepileptic Drugs，AEDs Sales Forecast by Country (2027-2032) & (K Units) Table 221. Europe Antiepileptic Drugs，AEDs Sales Market Share Forecast by Country (2027-2032) Table 222. Europe Antiepileptic Drugs，AEDs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 223. Europe Antiepileptic Drugs，AEDs Market Size by Country (2021-2026) & (US$ Million) Table 224. Europe Antiepileptic Drugs，AEDs Market Share by Country (2021-2026) Table 225. Europe Antiepileptic Drugs，AEDs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 226. Europe Antiepileptic Drugs，AEDs Market Share Forecast by Country (2027-2032) Table 227. Asia-Pacific Antiepileptic Drugs，AEDs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 228. Asia-Pacific Antiepileptic Drugs，AEDs Sales by Country (2021-2026) & (K Units) Table 229. Asia-Pacific Antiepileptic Drugs，AEDs Sales Market Share by Country (2021-2026) Table 230. Asia-Pacific Antiepileptic Drugs，AEDs Sales Forecast by Country (2027-2032) & (K Units) Table 231. Asia-Pacific Antiepileptic Drugs，AEDs Sales Market Share Forecast by Country (2027-2032) Table 232. Asia-Pacific Antiepileptic Drugs，AEDs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 233. Asia-Pacific Antiepileptic Drugs，AEDs Market Size by Country (2021-2026) & (US$ Million) Table 234. Asia-Pacific Antiepileptic Drugs，AEDs Market Share by Country (2021-2026) Table 235. Asia-Pacific Antiepileptic Drugs，AEDs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 236. Asia-Pacific Antiepileptic Drugs，AEDs Market Share Forecast by Country (2027-2032) Table 237. Latin America Antiepileptic Drugs，AEDs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 238. Latin America Antiepileptic Drugs，AEDs Sales by Country (2021-2026) & (K Units) Table 239. Latin America Antiepileptic Drugs，AEDs Sales Market Share by Country (2021-2026) Table 240. Latin America Antiepileptic Drugs，AEDs Sales Forecast by Country (2027-2032) & (K Units) Table 241. Latin America Antiepileptic Drugs，AEDs Sales Market Share Forecast by Country (2027-2032) Table 242. Latin America Antiepileptic Drugs，AEDs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 243. Latin America Antiepileptic Drugs，AEDs Market Size by Country (2021-2026) & (US$ Million) Table 244. Latin America Antiepileptic Drugs，AEDs Market Share by Country (2021-2026) Table 245. Latin America Antiepileptic Drugs，AEDs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 246. Latin America Antiepileptic Drugs，AEDs Market Share Forecast by Country (2027-2032) Table 247. Middle East and Africa Antiepileptic Drugs，AEDs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 248. Middle East and Africa Antiepileptic Drugs，AEDs Sales by Country (2021-2026) & (K Units) Table 249. Middle East and Africa Antiepileptic Drugs，AEDs Sales Market Share by Country (2021-2026) Table 250. Middle East and Africa Antiepileptic Drugs，AEDs Sales Forecast by Country (2027-2032) & (K Units) Table 251. Middle East and Africa Antiepileptic Drugs，AEDs Sales Market Share Forecast by Country (2027-2032) Table 252. Middle East and Africa Antiepileptic Drugs，AEDs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 253. Middle East and Africa Antiepileptic Drugs，AEDs Market Size by Country (2021-2026) & (US$ Million) Table 254. Middle East and Africa Antiepileptic Drugs，AEDs Market Share by Country (2021-2026) Table 255. Middle East and Africa Antiepileptic Drugs，AEDs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 256. Middle East and Africa Antiepileptic Drugs，AEDs Market Share Forecast by Country (2027-2032) Table 257. Key Raw Materials Table 258. Raw Materials Key Suppliers Table 259. Antiepileptic Drugs，AEDs Distributors List Table 260. Antiepileptic Drugs，AEDs Customers List Table 261. Research Programs/Design for This Report Table 262. Authors List of This Report Table 263. Secondary Sources Table 264. Primary Sources List of Figures Figure 1. Antiepileptic Drugs，AEDs Image Figure 2. Global Antiepileptic Drugs，AEDs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antiepileptic Drugs，AEDs Market Size (2021-2032) & (US$ Million) Figure 4. Global Antiepileptic Drugs，AEDs Sales (2021-2032) & (K Units) Figure 5. First Generation AEDs Image Figure 6. Global First Generation AEDs Sales YoY Growth (2021-2032) & (K Units) Figure 7. Second Generation AEDs Image Figure 8. Global Second Generation AEDs Sales YoY Growth (2021-2032) & (K Units) Figure 9. Third Generation AEDs Image Figure 10. Global Third Generation AEDs Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Antiepileptic Drugs，AEDs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Antiepileptic Drugs，AEDs Market Share by Type 2025 VS 2032 Figure 13. North America Antiepileptic Drugs，AEDs Sales Market Share in Volume by Type in 2025 Figure 14. North America Antiepileptic Drugs，AEDs Sales Market Share in Value by Type in 2025 Figure 15. Europe Antiepileptic Drugs，AEDs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Antiepileptic Drugs，AEDs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Antiepileptic Drugs，AEDs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Antiepileptic Drugs，AEDs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Antiepileptic Drugs，AEDs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Antiepileptic Drugs，AEDs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Antiepileptic Drugs，AEDs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Antiepileptic Drugs，AEDs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Antiepileptic Drugs，AEDs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. ≤15 Years Old Image Figure 26. Global ≤15 Years Old Sales YoY Growth (2021-2032) & (K Units) Figure 27. 15～40 Years Old Image Figure 28. Global 15～40 Years Old Sales YoY Growth (2021-2032) & (K Units) Figure 29. >40～65 Years Old Image Figure 30. Global >40～65 Years Old Sales YoY Growth (2021-2032) & (K Units) Figure 31. >65 Years Old Image Figure 32. Global >65 Years Old Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Antiepileptic Drugs，AEDs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Antiepileptic Drugs，AEDs Market Share by Application 2025 VS 2032 Figure 35. North America Antiepileptic Drugs，AEDs Sales Market Share in Volume by Application in 2025 Figure 36. North America Antiepileptic Drugs，AEDs Sales Market Share in Value by Application in 2025 Figure 37. Europe Antiepileptic Drugs，AEDs Sales Market Share in Volume by Application in 2025 Figure 38. Europe Antiepileptic Drugs，AEDs Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Antiepileptic Drugs，AEDs Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Antiepileptic Drugs，AEDs Sales Market Share in Value by Application in 2025 Figure 41. Latin America Antiepileptic Drugs，AEDs Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Antiepileptic Drugs，AEDs Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Antiepileptic Drugs，AEDs Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Antiepileptic Drugs，AEDs Sales Market Share in Value by Application in 2025 Figure 45. North America Antiepileptic Drugs，AEDs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Antiepileptic Drugs，AEDs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Antiepileptic Drugs，AEDs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Antiepileptic Drugs，AEDs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Antiepileptic Drugs，AEDs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Antiepileptic Drugs，AEDs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Antiepileptic Drugs，AEDs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Antiepileptic Drugs，AEDs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Antiepileptic Drugs，AEDs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Antiepileptic Drugs，AEDs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Antiepileptic Drugs，AEDs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Antiepileptic Drugs，AEDs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Antiepileptic Drugs，AEDs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Antiepileptic Drugs，AEDs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Antiepileptic Drugs，AEDs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Antiepileptic Drugs，AEDs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Antiepileptic Drugs，AEDs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Antiepileptic Drugs，AEDs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Antiepileptic Drugs，AEDs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Antiepileptic Drugs，AEDs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Antiepileptic Drugs，AEDs Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Antiepileptic Drugs，AEDs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • First Generation AEDs
  • Second Generation AEDs
  • Third Generation AEDs
Applications
  • ≤15 Years Old
  • 15～40 Years Old
  • >40～65 Years Old
  • >65 Years Old
Companies covered
  • Novartis
  • Pfizer
  • GlaxoSmithKline
  • Eisai
  • Roche
  • Shanghai Pharmaceuticals Holding
  • Gilead Sciences
  • UCB
  • Johnson & Johnson
  • Lupin Pharmaceuticals
  • Mylan N.V.
  • Sanofi
  • Teva Pharmaceutical Industries
  • Abbott
  • Sunovion
  • Shenzhen Salubris Pharmaceuticals
  • Chongqing Shenghuaxi Pharm
  • Zhejiang Jingxin Pharmaceutical
  • Zhuhai United Laboratories
  • Hubei Jumpcan Pharmaceutical
  • Zhejiang Huahai Pharmaceutical
  • China Resources SAIKE Pharmaceutical
  • Sihuan Pharmaceutical Holdings
  • Apeloa Pharmaceutical
  • Sandoz
  • Aurobindo Pharma
  • Yangtze River Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antiepileptic Drugs，AEDs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antiepileptic Drugs，AEDs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antiepileptic Drugs，AEDs Market by Type
  6. 1.3.1 First Generation AEDs
  7. 1.3.2 Second Generation AEDs
  8. 1.3.3 Third Generation AEDs
  9. 1.4 Global Antiepileptic Drugs，AEDs Market Size by Type
  10. 1.4.1 Global Antiepileptic Drugs，AEDs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Antiepileptic Drugs，AEDs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Antiepileptic Drugs，AEDs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Antiepileptic Drugs，AEDs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Antiepileptic Drugs，AEDs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Antiepileptic Drugs，AEDs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Antiepileptic Drugs，AEDs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Antiepileptic Drugs，AEDs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antiepileptic Drugs，AEDs Industry Trends
  2. 2.2 Antiepileptic Drugs，AEDs Industry Drivers
  3. 2.3 Antiepileptic Drugs，AEDs Industry Opportunities and Challenges
  4. 2.4 Antiepileptic Drugs，AEDs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antiepileptic Drugs，AEDs Revenue (2021-2026)
  2. 3.2 Global Top Players by Antiepileptic Drugs，AEDs Sales (2021-2026)
  3. 3.3 Global Top Players by Antiepileptic Drugs，AEDs Price (2021-2026)
  4. 3.4 Global Antiepileptic Drugs，AEDs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antiepileptic Drugs，AEDs Major Company Production Sites & Headquarters
  6. 3.6 Global Antiepileptic Drugs，AEDs Company, Product Type & Application
  7. 3.7 Global Antiepileptic Drugs，AEDs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antiepileptic Drugs，AEDs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antiepileptic Drugs，AEDs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antiepileptic Drugs，AEDs Tier 1, Tier 2, and Tier 3
4 Antiepileptic Drugs，AEDs Regional Status and Outlook
  1. 4.1 Global Antiepileptic Drugs，AEDs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antiepileptic Drugs，AEDs Historic Market Size by Region
  3. 4.2.1 Global Antiepileptic Drugs，AEDs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antiepileptic Drugs，AEDs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antiepileptic Drugs，AEDs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antiepileptic Drugs，AEDs Forecasted Market Size by Region
  7. 4.3.1 Global Antiepileptic Drugs，AEDs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antiepileptic Drugs，AEDs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antiepileptic Drugs，AEDs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antiepileptic Drugs，AEDs by Application
  1. 5.1 Antiepileptic Drugs，AEDs Market by Application
  2. 5.1.1 ≤15 Years Old
  3. 5.1.2 15～40 Years Old
  4. 5.1.3 >40～65 Years Old
  5. 5.1.4 >65 Years Old
  6. 5.2 Global Antiepileptic Drugs，AEDs Market Size by Application
  7. 5.2.1 Global Antiepileptic Drugs，AEDs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Antiepileptic Drugs，AEDs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Antiepileptic Drugs，AEDs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Antiepileptic Drugs，AEDs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Antiepileptic Drugs，AEDs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Antiepileptic Drugs，AEDs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Antiepileptic Drugs，AEDs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Antiepileptic Drugs，AEDs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Antiepileptic Drugs，AEDs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Antiepileptic Drugs，AEDs Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Antiepileptic Drugs，AEDs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Antiepileptic Drugs，AEDs Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 GlaxoSmithKline
  14. 6.3.1 GlaxoSmithKline Company Information
  15. 6.3.2 GlaxoSmithKline Business Overview
  16. 6.3.3 GlaxoSmithKline Antiepileptic Drugs，AEDs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GlaxoSmithKline Antiepileptic Drugs，AEDs Product Portfolio
  18. 6.3.5 GlaxoSmithKline Recent Developments
  19. 6.4 Eisai
  20. 6.4.1 Eisai Company Information
  21. 6.4.2 Eisai Business Overview
  22. 6.4.3 Eisai Antiepileptic Drugs，AEDs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Eisai Antiepileptic Drugs，AEDs Product Portfolio
  24. 6.4.5 Eisai Recent Developments
  25. 6.5 Roche
  26. 6.5.1 Roche Company Information
  27. 6.5.2 Roche Business Overview
  28. 6.5.3 Roche Antiepileptic Drugs，AEDs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Roche Antiepileptic Drugs，AEDs Product Portfolio
  30. 6.5.5 Roche Recent Developments
  31. 6.6 Shanghai Pharmaceuticals Holding
  32. 6.6.1 Shanghai Pharmaceuticals Holding Company Information
  33. 6.6.2 Shanghai Pharmaceuticals Holding Business Overview
  34. 6.6.3 Shanghai Pharmaceuticals Holding Antiepileptic Drugs，AEDs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shanghai Pharmaceuticals Holding Antiepileptic Drugs，AEDs Product Portfolio
  36. 6.6.5 Shanghai Pharmaceuticals Holding Recent Developments
  37. 6.7 Gilead Sciences
  38. 6.7.1 Gilead Sciences Company Information
  39. 6.7.2 Gilead Sciences Business Overview
  40. 6.7.3 Gilead Sciences Antiepileptic Drugs，AEDs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Gilead Sciences Antiepileptic Drugs，AEDs Product Portfolio
  42. 6.7.5 Gilead Sciences Recent Developments
  43. 6.8 UCB
  44. 6.8.1 UCB Company Information
  45. 6.8.2 UCB Business Overview
  46. 6.8.3 UCB Antiepileptic Drugs，AEDs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 UCB Antiepileptic Drugs，AEDs Product Portfolio
  48. 6.8.5 UCB Recent Developments
  49. 6.9 Johnson & Johnson
  50. 6.9.1 Johnson & Johnson Company Information
  51. 6.9.2 Johnson & Johnson Business Overview
  52. 6.9.3 Johnson & Johnson Antiepileptic Drugs，AEDs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Johnson & Johnson Antiepileptic Drugs，AEDs Product Portfolio
  54. 6.9.5 Johnson & Johnson Recent Developments
  55. 6.10 Lupin Pharmaceuticals
  56. 6.10.1 Lupin Pharmaceuticals Company Information
  57. 6.10.2 Lupin Pharmaceuticals Business Overview
  58. 6.10.3 Lupin Pharmaceuticals Antiepileptic Drugs，AEDs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Lupin Pharmaceuticals Antiepileptic Drugs，AEDs Product Portfolio
  60. 6.10.5 Lupin Pharmaceuticals Recent Developments
  61. 6.11 Mylan N.V.
  62. 6.11.1 Mylan N.V. Company Information
  63. 6.11.2 Mylan N.V. Business Overview
  64. 6.11.3 Mylan N.V. Antiepileptic Drugs，AEDs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Mylan N.V. Antiepileptic Drugs，AEDs Product Portfolio
  66. 6.11.5 Mylan N.V. Recent Developments
  67. 6.12 Sanofi
  68. 6.12.1 Sanofi Company Information
  69. 6.12.2 Sanofi Business Overview
  70. 6.12.3 Sanofi Antiepileptic Drugs，AEDs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Sanofi Antiepileptic Drugs，AEDs Product Portfolio
  72. 6.12.5 Sanofi Recent Developments
  73. 6.13 Teva Pharmaceutical Industries
  74. 6.13.1 Teva Pharmaceutical Industries Company Information
  75. 6.13.2 Teva Pharmaceutical Industries Business Overview
  76. 6.13.3 Teva Pharmaceutical Industries Antiepileptic Drugs，AEDs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Teva Pharmaceutical Industries Antiepileptic Drugs，AEDs Product Portfolio
  78. 6.13.5 Teva Pharmaceutical Industries Recent Developments
  79. 6.14 Abbott
  80. 6.14.1 Abbott Company Information
  81. 6.14.2 Abbott Business Overview
  82. 6.14.3 Abbott Antiepileptic Drugs，AEDs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Abbott Antiepileptic Drugs，AEDs Product Portfolio
  84. 6.14.5 Abbott Recent Developments
  85. 6.15 Sunovion
  86. 6.15.1 Sunovion Company Information
  87. 6.15.2 Sunovion Business Overview
  88. 6.15.3 Sunovion Antiepileptic Drugs，AEDs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Sunovion Antiepileptic Drugs，AEDs Product Portfolio
  90. 6.15.5 Sunovion Recent Developments
  91. 6.16 Shenzhen Salubris Pharmaceuticals
  92. 6.16.1 Shenzhen Salubris Pharmaceuticals Company Information
  93. 6.16.2 Shenzhen Salubris Pharmaceuticals Business Overview
  94. 6.16.3 Shenzhen Salubris Pharmaceuticals Antiepileptic Drugs，AEDs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Shenzhen Salubris Pharmaceuticals Antiepileptic Drugs，AEDs Product Portfolio
  96. 6.16.5 Shenzhen Salubris Pharmaceuticals Recent Developments
  97. 6.17 Chongqing Shenghuaxi Pharm
  98. 6.17.1 Chongqing Shenghuaxi Pharm Company Information
  99. 6.17.2 Chongqing Shenghuaxi Pharm Business Overview
  100. 6.17.3 Chongqing Shenghuaxi Pharm Antiepileptic Drugs，AEDs Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Chongqing Shenghuaxi Pharm Antiepileptic Drugs，AEDs Product Portfolio
  102. 6.17.5 Chongqing Shenghuaxi Pharm Recent Developments
  103. 6.18 Zhejiang Jingxin Pharmaceutical
  104. 6.18.1 Zhejiang Jingxin Pharmaceutical Company Information
  105. 6.18.2 Zhejiang Jingxin Pharmaceutical Business Overview
  106. 6.18.3 Zhejiang Jingxin Pharmaceutical Antiepileptic Drugs，AEDs Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Zhejiang Jingxin Pharmaceutical Antiepileptic Drugs，AEDs Product Portfolio
  108. 6.18.5 Zhejiang Jingxin Pharmaceutical Recent Developments
  109. 6.19 Zhuhai United Laboratories
  110. 6.19.1 Zhuhai United Laboratories Company Information
  111. 6.19.2 Zhuhai United Laboratories Business Overview
  112. 6.19.3 Zhuhai United Laboratories Antiepileptic Drugs，AEDs Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Zhuhai United Laboratories Antiepileptic Drugs，AEDs Product Portfolio
  114. 6.19.5 Zhuhai United Laboratories Recent Developments
  115. 6.20 Hubei Jumpcan Pharmaceutical
  116. 6.20.1 Hubei Jumpcan Pharmaceutical Company Information
  117. 6.20.2 Hubei Jumpcan Pharmaceutical Business Overview
  118. 6.20.3 Hubei Jumpcan Pharmaceutical Antiepileptic Drugs，AEDs Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Hubei Jumpcan Pharmaceutical Antiepileptic Drugs，AEDs Product Portfolio
  120. 6.20.5 Hubei Jumpcan Pharmaceutical Recent Developments
  121. 6.21 Zhejiang Huahai Pharmaceutical
  122. 6.21.1 Zhejiang Huahai Pharmaceutical Company Information
  123. 6.21.2 Zhejiang Huahai Pharmaceutical Business Overview
  124. 6.21.3 Zhejiang Huahai Pharmaceutical Antiepileptic Drugs，AEDs Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Zhejiang Huahai Pharmaceutical Antiepileptic Drugs，AEDs Product Portfolio
  126. 6.21.5 Zhejiang Huahai Pharmaceutical Recent Developments
  127. 6.22 China Resources SAIKE Pharmaceutical
  128. 6.22.1 China Resources SAIKE Pharmaceutical Company Information
  129. 6.22.2 China Resources SAIKE Pharmaceutical Business Overview
  130. 6.22.3 China Resources SAIKE Pharmaceutical Antiepileptic Drugs，AEDs Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 China Resources SAIKE Pharmaceutical Antiepileptic Drugs，AEDs Product Portfolio
  132. 6.22.5 China Resources SAIKE Pharmaceutical Recent Developments
  133. 6.23 Sihuan Pharmaceutical Holdings
  134. 6.23.1 Sihuan Pharmaceutical Holdings Company Information
  135. 6.23.2 Sihuan Pharmaceutical Holdings Business Overview
  136. 6.23.3 Sihuan Pharmaceutical Holdings Antiepileptic Drugs，AEDs Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Sihuan Pharmaceutical Holdings Antiepileptic Drugs，AEDs Product Portfolio
  138. 6.23.5 Sihuan Pharmaceutical Holdings Recent Developments
  139. 6.24 Apeloa Pharmaceutical
  140. 6.24.1 Apeloa Pharmaceutical Company Information
  141. 6.24.2 Apeloa Pharmaceutical Business Overview
  142. 6.24.3 Apeloa Pharmaceutical Antiepileptic Drugs，AEDs Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Apeloa Pharmaceutical Antiepileptic Drugs，AEDs Product Portfolio
  144. 6.24.5 Apeloa Pharmaceutical Recent Developments
  145. 6.25 Sandoz
  146. 6.25.1 Sandoz Company Information
  147. 6.25.2 Sandoz Business Overview
  148. 6.25.3 Sandoz Antiepileptic Drugs，AEDs Sales, Revenue and Gross Margin (2021-2026)
  149. 6.25.4 Sandoz Antiepileptic Drugs，AEDs Product Portfolio
  150. 6.25.5 Sandoz Recent Developments
  151. 6.26 Aurobindo Pharma
  152. 6.26.1 Aurobindo Pharma Company Information
  153. 6.26.2 Aurobindo Pharma Business Overview
  154. 6.26.3 Aurobindo Pharma Antiepileptic Drugs，AEDs Sales, Revenue and Gross Margin (2021-2026)
  155. 6.26.4 Aurobindo Pharma Antiepileptic Drugs，AEDs Product Portfolio
  156. 6.26.5 Aurobindo Pharma Recent Developments
  157. 6.27 Yangtze River Pharmaceutical
  158. 6.27.1 Yangtze River Pharmaceutical Company Information
  159. 6.27.2 Yangtze River Pharmaceutical Business Overview
  160. 6.27.3 Yangtze River Pharmaceutical Antiepileptic Drugs，AEDs Sales, Revenue and Gross Margin (2021-2026)
  161. 6.27.4 Yangtze River Pharmaceutical Antiepileptic Drugs，AEDs Product Portfolio
  162. 6.27.5 Yangtze River Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Antiepileptic Drugs，AEDs Sales by Country
  2. 7.1.1 North America Antiepileptic Drugs，AEDs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antiepileptic Drugs，AEDs Sales by Country (2021-2026)
  4. 7.1.3 North America Antiepileptic Drugs，AEDs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antiepileptic Drugs，AEDs Market Size by Country
  6. 7.2.1 North America Antiepileptic Drugs，AEDs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antiepileptic Drugs，AEDs Market Size by Country (2021-2026)
  8. 7.2.3 North America Antiepileptic Drugs，AEDs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antiepileptic Drugs，AEDs Sales by Country
  2. 8.1.1 Europe Antiepileptic Drugs，AEDs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antiepileptic Drugs，AEDs Sales by Country (2021-2026)
  4. 8.1.3 Europe Antiepileptic Drugs，AEDs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antiepileptic Drugs，AEDs Market Size by Country
  6. 8.2.1 Europe Antiepileptic Drugs，AEDs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antiepileptic Drugs，AEDs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antiepileptic Drugs，AEDs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antiepileptic Drugs，AEDs Sales by Country
  2. 9.1.1 Asia-Pacific Antiepileptic Drugs，AEDs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antiepileptic Drugs，AEDs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antiepileptic Drugs，AEDs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antiepileptic Drugs，AEDs Market Size by Country
  6. 9.2.1 Asia-Pacific Antiepileptic Drugs，AEDs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antiepileptic Drugs，AEDs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antiepileptic Drugs，AEDs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antiepileptic Drugs，AEDs Sales by Country
  2. 10.1.1 South America Antiepileptic Drugs，AEDs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antiepileptic Drugs，AEDs Sales by Country (2021-2026)
  4. 10.1.3 South America Antiepileptic Drugs，AEDs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antiepileptic Drugs，AEDs Market Size by Country
  6. 10.2.1 South America Antiepileptic Drugs，AEDs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antiepileptic Drugs，AEDs Market Size by Country (2021-2026)
  8. 10.2.3 South America Antiepileptic Drugs，AEDs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antiepileptic Drugs，AEDs Sales by Country
  2. 11.1.1 Middle East and Africa Antiepileptic Drugs，AEDs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antiepileptic Drugs，AEDs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antiepileptic Drugs，AEDs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antiepileptic Drugs，AEDs Market Size by Country
  6. 11.2.1 Middle East and Africa Antiepileptic Drugs，AEDs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antiepileptic Drugs，AEDs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antiepileptic Drugs，AEDs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antiepileptic Drugs，AEDs Value Chain Analysis
  2. 12.1.1 Antiepileptic Drugs，AEDs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antiepileptic Drugs，AEDs Production Mode & Process
  7. 12.2 Antiepileptic Drugs，AEDs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antiepileptic Drugs，AEDs Distributors
  10. 12.2.3 Antiepileptic Drugs，AEDs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst